Babu Padanilam is A. Ross McIntyre professor and Director of the Renal Program in the department of Cellular and Integrative Physiology at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska. He completed his Bachelors and Masters degrees in chemistry, in 1977 and 1979 respectively, from St. Berchmans’ college in Kerala University, India. He obtained his Ph.D. in 1985 from the Medical College of Georgia at Augusta, Georgia, USA. After postdoctoral trainings at Baylor College of Medicine and the University of Iowa, he joined Washington University, St. Louis as a research assistant professor in 1994. He joined UNMC as an associate professor in 2000.
The major focus of the Padanilam laboratory is to study the mechanisms of cellular injury in acute kidney injury (AKI) and renal fibrogenesis in chronic kidney disease (CKD) models. The role of neural factors, fatty acid oxidation and epoxyeicosatrienoic acids (EETs) in the regulation of renal fibrogenesis in different models of AKI and CKD. In collaborative projects, the laboratory is developing novel drug delivery approaches in AKI and CKD and characterizing a novel mouse model of congenital obstructive nephropathy.
Dr. Padanilam has served on grant review committees for the NIH, the Veterans Administration, American Heart Association, several states (Nebraska and Florida), the Wellcome Trust (UK) and the research grants council (Hong Kong). He is an editorial member of AJP-Renal and reviewer for numerous other journals. He served on the Biosciences Research Advisory Group of the American Society of Nephrology. He has given invited lectures on acute and chronic kidney diseases at national and international meetings.
